Test Bank For Clayton-s Basic Pharmacology for Nurses, 24th - 2023 All Chapters - 9780323812566.pdf

TestbBankbForbClayton’sbBasicbPharmacologybforbNursesb19thbEdition 1




COMPELETE TESTBANK b




TESTBANK FOR CLAYON’S BASIC PHARMACOLOGY F
b b b b b


OR NURSES 19TH EDITION/ WILLIHNGANZ VERIFIED Q
b b b b b b


UESTIONS AND ANSWERS WITH 2024 UPDATES (ALL C
b b b b b b b


HAPTERS INLUDED 1-48) b b

,TestbBankbForbClayton’sbBasicbPharmacologybforbNursesb19thbEdition 2




Chapter 01: Drug Definitions, Standards, and Information Sources Willihnganz
b b b b b b b b

: Clayton’s Basic Pharmacology for Nurses, 19th Edition
b b b b b b b




1. WhichbnamebidentifiesbabdrugblistedbbybthebUSbFoodbDrugb
Administrationb(FDA)?
a. Bran
b. Nonproprietar
c. Official
d. Trademark
ANS:
Thebofficialbnamebisbthebnamebunderbwhichbabdrugbisblistedbbybth
ebFDA.bThebbrandbname,borbtrademark,bisbthebnamebgivenbtobabdr
ugbbybitsbmanufacturer.bThebnonproprietary,borbgeneric,bnamebis
bprovidedbbybthebUnitedbStatesbAdoptedbNamesbCouncil.

CognitivebLevel:bKnowledge REF:b p.b9
OBJ:b1NAT:bNCLEXbClientbNeedsbCategory:bSafe,bEffectivebCareb
EnvironmentbTOP:b NursingbProcessbStep:bAssessment
CON:b
PatientbEducation




2. Whichbsourcebcontainsbinformationbspecificbtobnutritionalbsupplements?
a. USPbDictionarybofbUSANb &bInternationalbDrugbNames
b. NaturalbMedicinesbComprehensivebDatabase
c. UnitedbStatesbPharmacopoeia/NationalbFormularyb(USPbNF)
d. DrugbInteractionbFacts
ANS:bC
UnitedbStatesbPharmacopoeia/NationalbFormularybcontainsbinformationbspecificbtobnutritionalbsupp
lements.bUSPbDictionarybofbUSANb&bInternationalbDrugbNamesbisbabcompilationbofbdrugbnames,bpr
onunciationbguide,bandbpossiblebfuturebFDAbapprovedbdrugs;bitbdoesbnotbincludebnutritionalbsupple
ments.bNaturalbMedicinesbComprehensivebDatabasebcontains
evidence-
basedbinformationbonbherbalbmedicinesbandbherbalbcombinationbproducts;bitbdoesbnotbincludebinf
ormationbspecificbtobnutritionalbsupplements.bDrugbInteractionbFactsbcontainsbcomprehensivebi
nformationbonbdrugbinteractionbfacts;bitbdoesbnotbincludebnutritionalbsupplements.

DIF: CognitivebLevel:bKnowledge REF:b p.b4
OBJ:b3bNAT:b NCLEXbClientbNeedsbCategory:bPhysiologicalbInteg
rity
TOP:b NursingbProcessbStep:bAssessment CON:b Nutritionb|bPatientbEducation

3. Whichbdrugbreferencebcontainsbdrugbmonographsbthatbdescribeballbdrugsbinbabtherapeuticbclass?
a. DrugbFactsbandbComparisons

,TestbBankbForbClayton’sbBasicbPharmacologybforbNursesb19thbEdition 3

b. DrugbInteractionbFacts
c. HandbookbonbInjectablebDrugs
d. Martindale—ThebCompletebDrugbReference

ANS:bA
DrugbFactsbandbComparisonsbcontainsbdrugbmonographsbthatbdescribeballbdrugsbinbabth
erapeuticbclass.bMonographsbarebformattedbasbtablesbtoballowbcomparisonbofbsimilarbpro
ducts,bbrandbnames,bmanufacturers,bcostbindices,bandbavailablebdosagebformsbOnlinebve
rsionbisbavailable.

DIF: CognitivebLevel:bKnowledge REF:b p.b4bTableb1.2
OBJ:b b 3 NAT:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
TOP:b NursingbProcessbStep:bAssessment CON:b Safetyb|bPatientbEducationb|bClinicalbJudgment

4. Whichbdrugbreferencebcontainsbmonographsbaboutbvirtuallybeverybsingle-
entitybdrugbavailablebinbthebUnitedbStatesbandbdescribesbtherapeuticbusesbofbdrugs,bincludingba
pprovedbandbunapprovedbuses?
a. Martindale:bThebCompletebDrugbReference
b. AHFSbDrugbInformation
c. DrugbReference
d. DrugbFactsbandbComparisons
ANS:bB
AHFSbDrugbInformationbcontainsbmonographsbaboutbvirtuallybeverybsingle-
entitybdrugbavailablebinbthebUnitedbStatesbandbdescribesbtherapeuticbusesbofbdrugs,bincludingbappr
ovedbandbunapprovedbuses.

DIF: CognitivebLevel:bKnowledge REF:b p.b4bTableb1.2
OBJ:b b 3 NAT:b NCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrity
TOP:b NursingbProcessbStep:bPlanning CON:b Safetyb|bPatientbEducationb|bClinicalbJudgment

5. Whichbonlinebdrugbreferencebmakesbavailablebtobhealthcarebprovidersbandbthebpublicbabstand
ard,bcomprehensive,bup-to-dateblookbupbandbdownloadablebresourcebaboutbmedicines?
a. AmericanbDrugbIndex
b. AmericanbHospitalbFormulary
c. DailyMed
d. DrugbReference
ANS:bC
DailyMedbmakesbavailablebtobhealthcarebprovidersbandbthebpublicbabstandard,bcomprehensive,b
up-to-
dateblookbupbandbdownloadablebresourcebaboutbmedicines.bThebAmericanbDrugbIndexbisbnotbapp
ropriatebforbpatientbuse.bThebAmericanbHospitalbFormularybisbnotbappropriatebforbpatientbuse.b
Thebdrugbreferencebisbnotbappropriatebforbpatientbuse.

DIF: CognitivebLevel:bKnowledge REF:b p.b3b|bp.b4
OBJ:b3bNAT:b NCLEXbClientbNeedsbCategory:bPhysiologicalbInteg
rity
TOP:b NursingbProcessbStep:bImplementation
CON:b Safetyb|bPatientbEducationb|bClinicalbJudgment

6. WhichblegislationbauthorizesbthebFDAbtobdeterminebthebsafetybofbabdrugbbeforebitsbmarketing?
a. FederalbFood,bDrug,bandbCosmeticbActb(1938)
b. DurhambHumphreybAmendmentb(1952)

, TestbBankbForbClayton’sbBasicbPharmacologybforbNursesb19thbEdition 4

c. ControlledbSubstancesbActb(1970)
d. KefauverbHarrisbDrugbAmendmentb(1962)
ANS:bA
ThebFederalbFood,bDrug,bandbCosmeticbActbofb1938bauthorizedbthebFDAbtobdeterminebthebsafet
ybofballbdrugsbbeforebmarketing.bLaterbamendmentsbandbactsbhelpedbtightenbFDAbcontrolbandben
surebdrugbsafety.bThebDurhambHumphreybAmendmentbdefinesbthebkindsbofbdrugsbthatbcannotbbe
busedbsafelybwithoutbmedicalbsupervisionbandbrestrictsbtheirbsalebtobprescriptionbbybablicensedbpr

actitioner.bThebControlledbSubstancesbActbaddressesbonlybcontrolledbsubstancesbandbtheirbcatego
rization.bThebKefauverbHarrisbDrugbAmendmentbensuresbdrugbefficacybandbgreaterbdrugbsafety.b
DrugbmanufacturersbarebrequiredbtobprovebtobthebFDAbthebeffectivenessbofbtheirbproductsbbefore
bmarketingbthem.




DIF: CognitivebLevel:bKnowledge REF:b p.b5bTablebl.3
OBJ:b 5
NAT:bNCLEXbClientbNeedsbCategory:bPhysiologicalbIntegrityb
TOP:b NursingbProcessbStep:bAssessment
CON:b Safetyb|bPatientbEducationb|bEvidenceb|bHealthbCarebLaw

7. Whichbclassificationbdoesbmeperidineb(Demerol)bfallbunder?
a. I
b. II
c. III
d. IV
ANS:bB
Meperidineb(Demerol)bisbabSchedulebIIbdrug;bitbhasbabhighbpotentialbforbabusebandbmaybleadbtobs
everebpsychologicalbandbphysicalbdependence.bSchedulebIbdrugsbhavebhighbpotentialbforbabuseban
dbnobrecognizedbmedicalbuse.bSchedulebIIIbdrugsbhavebsomebpotentialbforbabuse.bUsebmaybleadbt
oblowbtobmoderatebphysicalbdependenceborbhighbpsychologicalbdependence.bSchedulebIVbdrugsb
haveblowbpotentialbforbabuse.bUsebmaybleadbtoblimitedbphysicalborbpsychologicalbdependence.

DIF: CognitivebLevel:bKnowledge REF:b p.b10
OBJ:b2bNAT:b NCLEXbClientbNeedsbCategory:bSafe,bEffectivebCar
ebEnvironment
TOP:b NursingbProcessbStep:bAssessment CON:b PatientbEducationb|bAddictionb|bPain

8. WhichbactionbwouldbthebFDAbtakebtobexpeditebdrugbdevelopmentbandbapprovalbforbanboutbreakbo
fbsmallpox?
a. Listbsmallpoxbasbabhealthborphanbdisease.
b. Omitbthebpreclinicalbresearchbphase.
c. Extendbthebclinicalbresearchbphase.
d. Fastbtrackbthebinvestigationalbdrug.
ANS:bD
OncebthebInvestigationalbNewbDrugbApplicationbhasbbeenbapproved,bthebdrugbcanbreceivebhighe
stbprioritybwithinbthebagency,bwhichbisbcalledbfastbtracking.bAbsmallpoxboutbreakbwouldbbecome
babprioritybconcernbinbthebworld.bOrphanbdiseasesbarebnotbresearchedbinbabprioritybmanner.bPrecli

nicalbresearchbisbnotbomitted.bExtendingbanybphasebofbthebresearchbwouldbmeanbablongerbtimebtob
developbabvaccine.bThebFDAbmustbensurebthatballbphasesbofbthebpreclinicalbandbclinicalbresearchb
phasebhavebbeenbcompletedbinbabsafebmanner.

DIF: CognitivebLevel:bKnowledge REF:b p.b7 OBJ:b 5